Summary GLP-1 drugs, while effective for diabetes and weight loss, remain expensive even for insured patients. Many insurance plans require patients to share the cost, and some plans don’t cover GLP-1 drugs for weight loss. […]
Summary The FDA’s approval of over-the-counter continuous glucose monitors (CGMs) marks a significant advancement in diabetes management, expanding access to crucial health data without a prescription. These devices offer real-time glucose insights, empowering individuals to […]
Summary This article explores the impact of time-restricted eating on senior health, focusing on factors beyond weight loss. We delve into the potential benefits and risks of this dietary approach, considering its effects on metabolism, […]
Summary A recent CCS report highlights the urgent need for improved diabetes education and patient engagement. Many people with diabetes hold misconceptions about treatments, and healthcare providers feel overwhelmed by the growing number of patients. […]
Summary Disruptions to semaglutide treatment in diabetic patients raise concerns about glycemic control. This article explores the potential consequences of these interruptions and discusses strategies for mitigating their effects. The insights shared shed light on […]
Summary Scientists have identified molecular glues that protect insulin-producing cells from damage, offering a potential new treatment strategy for type 2 diabetes. This approach focuses on preserving beta cell function, unlike current therapies that primarily […]
Summary This article explores recent breakthroughs in diabetes management, focusing on how to optimize metabolism for better blood sugar control. We delve into the science behind metabolic processes and highlight promising research on the Plvap […]
Summary This article explores the groundbreaking research funded to combat diabetes distress, a significant emotional burden for individuals living with diabetes. It discusses the importance of emotional support in diabetes management and highlights the potential […]
Summary Tzield, a groundbreaking Type 1 diabetes drug, is now available at OU Health. This marks a significant advancement, offering potential delay and even prevention of clinical diagnosis. The future of diabetes management is evolving […]
Summary A groundbreaking new treatment strategy for type 2 diabetes could eliminate the need for insulin therapy in 86% of patients. This innovative approach combines a novel procedure known as ReCET (Re-Cellularization via Electroporation Therapy) […]
© 2025 Newsguru LTD. All rights reserved.